Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review
M Guirado, E Fernández Martín… - Clinical and …, 2022 - Springer
Introduction Due to the importance of lung cancer early treatment because of its severity and
extent worldwide a systematic literature review was conducted about the impact of delays in …
extent worldwide a systematic literature review was conducted about the impact of delays in …
European Respiratory Society guideline on various aspects of quality in lung cancer care
This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …
recommendations in lung cancer care. All the clinical recommendations contained were …
Machine learning radiomics model for early identification of small-cell lung cancer on computed tomography scans
RP Shah, HM Selby, P Mukherjee, S Verma… - JCO Clinical Cancer …, 2021 - ascopubs.org
PURPOSE Small-cell lung cancer (SCLC) is the deadliest form of lung cancer, partly
because of its short doubling time. Delays in imaging identification and diagnosis of nodules …
because of its short doubling time. Delays in imaging identification and diagnosis of nodules …
Comparative study of survival among small cell lung cancer patients in the US Military Health System and those in the Surveillance, Epidemiology, and End Results …
J Lin, C Kamamia, DW Brown, S Shao… - Annals of …, 2021 - Elsevier
Purpose: The US military health system provides universal health care access to
beneficiaries. However, whether the universal access has translated into improved patient …
beneficiaries. However, whether the universal access has translated into improved patient …
Timing of chemotherapy after diagnosis of small cell lung cancer
F Tas, A Ozturk, K Erturk - Journal of Chemotherapy, 2024 - Taylor & Francis
Systemic chemotherapy is the backbone of therapeutic management in small cell lung
cancer (SCLC) and delay of treatment may lead to adverse patient outcomes. This study was …
cancer (SCLC) and delay of treatment may lead to adverse patient outcomes. This study was …
Lung cancer; sex-related survival and optimising diagnostic pathways in a comprehensive population
D Lærum - 2024 - duo.uio.no
Lung cancer is an aggressive disease with a poor prognosis, apparently worse in males
than females. The diagnostic process is complex and time-consuming, and diagnostic …
than females. The diagnostic process is complex and time-consuming, and diagnostic …